Literature DB >> 21484773

Increase in future remnant liver function after preoperative portal vein embolization.

W de Graaf1, K P van Lienden, J W van den Esschert, R J Bennink, T M van Gulik.   

Abstract

BACKGROUND: Preoperative portal vein embolization (PVE) is performed in patients with insufficient future remnant liver (FRL) to allow safe resection. Although many studies have demonstrated an increase in FRL volume after PVE, little is known about the increase in FRL function. This study evaluated the increase in FRL function after PVE using (⁹⁹m) Tc-labelled mebrofenin hepatobiliary scintigraphy (HBS) with single photon emission computed tomography (SPECT) and compared this with the increase in FRL volume.
METHODS: In 24 patients, computed tomography volumetry and (⁹⁹m) Tc-labelled mebrofenin HBS with SPECT were performed before and 3-4 weeks after PVE to measure FRL volume, standardized FRL and FRL function. A hypothetical model was used to assess safe resectability after PVE. The limit for safe resection for FRL function was set at an uptake of 2·69 per cent per min per m². For FRL volume and standardized FRL, 25 or 40 per cent of total liver volume was used, depending on the presence of underlying liver disease.
RESULTS: After PVE, FRL function increased significantly more than FRL volume. The correlation between the increase in FRL volume and FRL function was poor. Using the hypothetical model, seven patients did not achieve a sufficient increase in FRL function to allow safe resection 3-4 weeks after PVE, compared with 12 and nine patients based on FRL volume and standardized FRL respectively.
CONCLUSION: The increase in FRL function after PVE is more pronounced than the increase in FRL volume, suggesting that the necessary waiting time until resection may be shorter than indicated by volumetric parameters.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484773     DOI: 10.1002/bjs.7456

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  52 in total

1.  Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization.

Authors:  Maciej Malinowski; Johan Friso Lock; Daniel Seehofer; Bernhard Gebauer; Antje Schulz; Lina Demirel; Jan Bednarsch; Victoria Stary; Peter Neuhaus; Martin Stockmann
Journal:  Surg Today       Date:  2015-12-31       Impact factor: 2.549

2.  Prediction of postoperative liver failure in patients diagnosed with hepatocellular carcinoma using (99m)Tc-GSA SPECT/CT.

Authors:  Kasia P Cieslak; Roelof J Bennink; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

3.  Percentage of future liver remnant volume before portal vein embolization influences the degree of liver regeneration after hepatectomy.

Authors:  Hirohisa Okabe; Toru Beppu; Shigeki Nakagawa; Morikatsu Yoshida; Hiromitsu Hayashi; Toshiro Masuda; Katsunori Imai; Kosuke Mima; Hideyuki Kuroki; Hidetoshi Nitta; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Masayuki Watanabe; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastrointest Surg       Date:  2013-05-29       Impact factor: 3.452

4.  Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI.

Authors:  Dominik Geisel; Lutz Lüdemann; Thomas Keuchel; Maciej Malinowski; Daniel Seehofer; Martin Stockmann; Bernd Hamm; Bernhard Gebauer; Timm Denecke
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

5.  Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.

Authors:  Toru Beppu; Hidetoshi Nitta; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Morikatsu Yoshida; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

Review 6.  A literature review of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): so far, so good.

Authors:  Martin de Santibañes; Luis Boccalatte; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2016-10-20

Review 7.  Portal vein embolization before liver resection: a systematic review.

Authors:  K P van Lienden; J W van den Esschert; W de Graaf; S Bipat; J S Lameris; T M van Gulik; O M van Delden
Journal:  Cardiovasc Intervent Radiol       Date:  2012-07-18       Impact factor: 2.740

8.  Liver kinetic growth rate predicts postoperative liver failure after ALPPS.

Authors:  Patryk Kambakamba; Daniel Stocker; Cäcilia S Reiner; Thi Dan Nguyen-Kim; Michael Linecker; Dilmurodjon Eshmuminov; Henrik Petrowsky; Pierre-Alain Clavien; Mickael Lesurtel
Journal:  HPB (Oxford)       Date:  2016-08-11       Impact factor: 3.647

9.  Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases.

Authors:  Christian Sturesson; Jan Nilsson; Sam Eriksson; Lidewij Spelt; Roland Andersson
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

10.  ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE).

Authors:  T F Ulmer; C de Jong; A Andert; P Bruners; C M Heidenhain; W Schoening; M Schmeding; U P Neumann
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.